DK1930414T3 - Fremgangsmåde til aktiveringsbehandling af antigenpræsenterende celle - Google Patents

Fremgangsmåde til aktiveringsbehandling af antigenpræsenterende celle

Info

Publication number: DK1930414T3
Authority: DK; Denmark
Prior art keywords: cell activation; antigen presenting; presenting cell; activating antigen; activating
Prior art date: 2005-09-08

Application number

DK06797441.0T

Other languages

English (en)

Inventor

Mie Nieda

Manami Isogai

Masashi Takahara

Andrew Nicol

Original Assignee

Medinet Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-08

Filing date

2006-09-05

Publication date

2012-10-22

2006-09-05 Application filed by Medinet Co Ltd filed Critical Medinet Co Ltd

2012-10-22 Application granted granted Critical

2012-10-22 Publication of DK1930414T3 publication Critical patent/DK1930414T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/57—Skin; melanoma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/46449—Melanoma antigens
- A61K39/464491—Melan-A/MART
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/464838—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Cell Biology (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Mycology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Hematology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Developmental Biology & Embryology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

DK06797441.0T 2005-09-08 2006-09-05 Fremgangsmåde til aktiveringsbehandling af antigenpræsenterende celle DK1930414T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2005295598		2005-09-08
JP2006112571		2006-04-14
PCT/JP2006/317535 WO2007029689A1 (ja)	2005-09-08	2006-09-05	抗原提示細胞の活性化処理方法

Publications (1)

Publication Number	Publication Date
DK1930414T3 true DK1930414T3 (da)	2012-10-22

Family

ID=37835809

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06797441.0T DK1930414T3 (da)	2005-09-08	2006-09-05	Fremgangsmåde til aktiveringsbehandling af antigenpræsenterende celle

Country Status (9)

Country	Link
US (2)	US8609410B2 (da)
EP (1)	EP1930414B1 (da)
JP (2)	JP5384827B2 (da)
KR (1)	KR101419711B1 (da)
CN (1)	CN101258238B (da)
AU (1)	AU2006288348B2 (da)
DK (1)	DK1930414T3 (da)
ES (1)	ES2391573T3 (da)
WO (1)	WO2007029689A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10254601A1 (de)	2002-11-22	2004-06-03	Ganymed Pharmaceuticals Ag	Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
WO2006006638A1 (ja) *	2004-07-08	2006-01-19	Medinet Co., Ltd	樹状細胞、該樹状細胞を含む医薬、該樹状細胞を用いた治療方法およびγδＴ細胞の培養方法
CN102137925B (zh) *	2008-07-01	2014-12-10	迈世耐特股份公司	同时诱导CTL和γδT细胞的方法
WO2012054807A2 (en)	2010-10-22	2012-04-26	President And Fellows Of Harvard College	Vaccines comprising bisphosphonate and methods of use thereof
WO2013174404A1 (en)	2012-05-23	2013-11-28	Ganymed Pharmaceuticals Ag	Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2013174403A1 (en) *	2012-05-23	2013-11-28	Ganymed Pharmaceuticals Ag	Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
US10093736B2 (en)	2012-11-13	2018-10-09	Biontech Ag	Agents for treatment of claudin expressing cancer diseases
CN102994448A (zh) *	2012-12-13	2013-03-27	上海柯莱逊生物技术有限公司	一种体外扩增γδT细胞的方法
CN104651308A (zh) *	2013-11-22	2015-05-27	深圳先进技术研究院	一种用磷酸盐扩增γδT细胞的方法及其应用
EA201790010A1 (ru)	2014-07-09	2017-05-31	ТиСи БАЙОФАРМ ЛТД.	Гамма-дельта t-клетки и их применение
GB201506423D0 (en)	2015-04-15	2015-05-27	Tc Biopharm Ltd	Gamma delta T cells and uses thereof
WO2016035808A1 (ja)	2014-09-03	2016-03-10	日東電工株式会社	ビスホスホネート剤を含む細胞性免疫用ワクチン医薬組成物
WO2016035809A1 (ja)	2014-09-03	2016-03-10	日東電工株式会社	ビスホスホネート剤を含む液性免疫用ワクチン医薬組成物
CN106190972A (zh) *	2015-04-30	2016-12-07	广州复大医疗股份有限公司	一种外周血γδT细胞的诱导扩增培养方法
CN108289902B (zh) *	2015-09-09	2022-05-20	清华大学	作为高效的疫苗佐剂的甲羟戊酸通路的抑制剂
EP3453755B1 (en)	2016-04-28	2023-06-28	Riken	Technology for efficient activation of nkt cells
CA3100200A1 (en) *	2018-05-21	2019-11-28	Nanostring Technologies, Inc.	Molecular gene signatures and methods of using same
CN110272870A (zh) *	2019-05-16	2019-09-24	安徽瑞达健康产业有限公司	一种细胞组合物在癌细胞nci-h1975上的应用
CN112089840B (zh) *	2020-10-27	2022-04-12	中南大学湘雅三医院	Ktn1-as1的抑制剂在制备治疗膀胱癌药物中的应用
CN113755599B (zh) *	2021-10-14	2023-12-26	四川大学华西医院	Grb7基因在结直肠癌的诊断、预后检测评价和药物制备中的应用
WO2024205257A1 (en) *	2023-03-28	2024-10-03	Pharmicell Co., Ltd.	Human cd141+ dendritic cells matured with zoledronate carrying wt1 information

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6821778B1 (en)	1993-12-01	2004-11-23	The Board Of Trustees Of Leland Stanford Junior University	Methods for using dendritic cells to activate gamma/delta-T cell receptor-positive T cells
US6429199B1 (en) *	1994-07-15	2002-08-06	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules for activating dendritic cells
US20040014724A1 (en) *	2001-05-09	2004-01-22	Seaman John J.	Method of administering a bisphosphonate
GB0012209D0 (en) *	2000-05-19	2000-07-12	Novartis Ag	Organic compounds
US20030133913A1 (en) *	2001-08-30	2003-07-17	3M Innovative Properties Company	Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
WO2006006638A1 (ja)	2004-07-08	2006-01-19	Medinet Co., Ltd	樹状細胞、該樹状細胞を含む医薬、該樹状細胞を用いた治療方法およびγδＴ細胞の培養方法

2006
- 2006-09-05 DK DK06797441.0T patent/DK1930414T3/da active
- 2006-09-05 ES ES06797441T patent/ES2391573T3/es active Active
- 2006-09-05 WO PCT/JP2006/317535 patent/WO2007029689A1/ja active Application Filing
- 2006-09-05 EP EP06797441A patent/EP1930414B1/en active Active
- 2006-09-05 AU AU2006288348A patent/AU2006288348B2/en active Active
- 2006-09-05 CN CN200680032855.6A patent/CN101258238B/zh active Active
- 2006-09-05 US US12/066,313 patent/US8609410B2/en active Active
- 2006-09-05 JP JP2007534425A patent/JP5384827B2/ja active Active
- 2006-09-05 KR KR1020087007237A patent/KR101419711B1/ko active IP Right Grant
2013
- 2013-02-18 JP JP2013029172A patent/JP5307944B2/ja active Active
- 2013-11-12 US US14/077,671 patent/US20140073050A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR101419711B1 (ko)	2014-07-17
ES2391573T3 (es)	2012-11-27
EP1930414A4 (en)	2009-04-15
AU2006288348B2 (en)	2012-05-03
AU2006288348A1 (en)	2007-03-15
EP1930414B1 (en)	2012-07-18
US20090104161A1 (en)	2009-04-23
US8609410B2 (en)	2013-12-17
EP1930414A1 (en)	2008-06-11
KR20080059166A (ko)	2008-06-26
WO2007029689A1 (ja)	2007-03-15
JP5384827B2 (ja)	2014-01-08
JP5307944B2 (ja)	2013-10-02
CN101258238A (zh)	2008-09-03
CN101258238B (zh)	2014-07-09
JP2013150609A (ja)	2013-08-08
JPWO2007029689A1 (ja)	2009-03-19
US20140073050A1 (en)	2014-03-13

Publication	Publication Date	Title
DK1930414T3 (da)	2012-10-22	Fremgangsmåde til aktiveringsbehandling af antigenpræsenterende celle
DK3494882T3 (da)	2021-05-10	Indretning til overvågning af analytter
DK1852430T3 (da)	2019-08-05	Fremgangsmåde til fremstilling af proanthocyanidinoligomer
DE602007004421D1 (de)	2010-03-11	Zellkulturvorrichtung
DK1879623T3 (da)	2012-12-17	Genterapi til rygmarvssygdomme
DK2054711T3 (da)	2020-12-14	Fremgangsmåde til fremstilling af mikroarrays
FR2881809B1 (fr)	2007-04-13	Bloqueur de lacet rapide
DK1926582T3 (da)	2012-08-20	Fremgangsmåder til beredning af læder
DE602007008787D1 (de)	2010-10-14	Spannvorrichtung
FI20055649A (fi)	2007-06-08	Paikanmääritystekniikoita
DE112006000958B8 (de)	2013-03-07	Brennstoffzelle
DK1984744T3 (da)	2012-12-10	Fremgangsmåder og sæt til diagnostisering af væksthormonmangel
DE602006012891D1 (de)	2010-04-29	Brennstoffzellenseparator
FI20065363A0 (fi)	2006-05-30	Erotusmenetelmä
DK2027150T3 (da)	2012-08-20	Allo-begrænsede peptid-specifikke t-celler
DE112007001674A5 (de)	2009-04-16	Spannvorrichtung
DK1976884T3 (da)	2013-02-25	Anti-ephrinb2-antistoffer og fremgangsmåder til anvendelse deraf.
DE502006007466D1 (de)	2010-09-02	Laser-Mikrodissektionsgerät
DK2217376T3 (da)	2013-04-15	Kuvette og fremgangsmåde til anvendelse af denne kuvette
DE602005017745D1 (de)	2009-12-31	Brennstoffzellen-auseinanderbauverfahren
DK1931998T3 (da)	2010-10-11	Fremgangsmåde til kvantificering af allergener
DK2094728T3 (da)	2013-07-01	Fremgangsmåder til anvendelse for human-adapterende monoklonale antistoffer
DE602006020338D1 (de)	2011-04-07	Brennstoffzelle
DE602006001060D1 (de)	2008-06-19	Brennstoffzelle
DE602006016532D1 (de)	2010-10-14	Brennstoffzelle